Q&A with Gunnar Weikert, Former Bayer VP (Part I) | GenomeWeb

NEW YORK, Nov 2 - Gunnar Weikert may not have name recognition in the scientific community, but he has been behind some of the biggest deals the genomics sector has ever seen

As senior vice president and global head of physiomics at Bayer, he was a key player in the

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."